Tamoxifen-Phospholipid Conjugate: A Promising Anticancer Therapeutic with Improved Antitumor Activity and Reduced Liver Toxicity. | Regional Centre for Biotechnology

Tamoxifen-Phospholipid Conjugate: A Promising Anticancer Therapeutic with Improved Antitumor Activity and Reduced Liver Toxicity.

Tamoxifen-Phospholipid Conjugate: A Promising Anticancer Therapeutic with Improved Antitumor Activity and Reduced Liver Toxicity.

नया क्या है

Consolidated list of waitlisted candidates selected (in order of merit) for admission to the i3c BRIC-RCB PhD Programme in Biosciences 2025-2026

Call for application BITP 2025-26

Allotment of seats after filling out the preference form (2nd Round) for admission to the i3c BRIC-RCB PhD Programme in Biosciences 2025-2026

Consolidated list of waitlisted candidates selected (in order of merit) for admission to the i3c BRIC-RCB PhD Programme in Biosciences 2025-2026

Allotment of seats after filling out the preference form (1st Round) for admission to the i3c BRIC-RCB PhD Programme in Biosciences 2025-2026

List of candidates selected/waitlisted for admission to the i3c BRIC-RCB PhD Programme in Biosciences 2025-2026

List of Provisionally Selected Candidates for MS-PhD Programme in Biotechnology Admissions 2025

List of provisionally shortlisted candidates for contractual position of Project Head under the project entitled “Setting up of the Indian Biological Data Centre (IBDC), Phase-I”

पिछला Pause अगला

अभिगम्यता उपकरण